The Genes, Environment and Health Initiative (GEI) of the National Institutes of Health (NIH) today awarded grants, estimated to be up to $5.5 million over two years for six studies aimed at finding genetic factors that influence the risks for stroke, glaucoma, high blood pressure, prostate cancer and other common disorders. ...
Data from the genome-wide association studies will be deposited in the database of Genotypes and Phenotypes (dbGaP) at the National Center for Biotechnology Information, a part of the National Library of Medicine at NIH, which will manage the vast amount of genetic, medical and environmental information that emerges from GEI. To encourage rapid research advances, and in keeping with the principles pioneered by the Human Genome Project, all data generated through these initiatives will be made available to researchers, consistent with NIH's data-sharing policy for NIH-supported, genome-wide association studies ....
For researchers who want to view genome-wide association data produced by GEI, dbGaP offers two levels of access. The first is open-access, which means the information will be available without restriction on the Internet, and the second is controlled-access, which requires preauthorization for the individual researcher seeking to view it. The open-access section will allow users to view study documents, such as protocols, questionnaires and summaries of phenotype data. The second is the controlled-access portion of the database, which allows approved researchers to download individual-level genotype and phenotype data from which the study participants' personal identifiers, such as names, have been removed. ...
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
